Sabejon, Jes Russel A.
HRN: 23-60-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/04/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/04/2023
09/10/2023
IV
120mg
OD
PCAP C
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes